Clinical Roundup Long-term analysis suggests follicular lymphoma can be cured, Fred Hutch study finds March 13, 2026Vol.52 No.10
Clinical Roundup Phase III persevERA study of giredestrant combination in ER-positive advanced breast cancer does not meet primary objective March 13, 2026Vol.52 No.10
Clinical Roundup Positive phase III results announced from the SUCCESSOR-2 study of oral mezigdomide in r/r MM March 13, 2026Vol.52 No.10
Clinical Roundup Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation March 13, 2026Vol.52 No.10
Clinical Roundup Johns Hopkins scientists engineer nanoparticles able to seek and destroy diseased immune cells March 13, 2026Vol.52 No.10
Clinical Roundup Nutrition therapy extends survival by 34% in stage 4 pancreatic cancer patients, clinical trial shows March 13, 2026Vol.52 No.10
Clinical Roundup Additional radiation for liver cancer doesn’t increase toxicity, University of Cincinnati study finds March 13, 2026Vol.52 No.10
Clinical Roundup Phase I data released from study of Lymphir dosing prior to commercial CAR T therapy in high‑risk diffuse large b‑cell lymphoma March 13, 2026Vol.52 No.10
Clinical Roundup Positive topline results announced from phase I study of Lymphir + pembrolizumab in r/r gynecologic cancers March 13, 2026Vol.52 No.10
Clinical Roundup Novel antibody blocks Epstein-Barr virus, Fred Hutch study finds March 13, 2026Vol.52 No.10
